|
|
Article: Acambis Gets $30M Vaccine Order, Settles With Novartis.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
West Coast Editor
With a decision due from the FDA early next year on its ACAM2000 smallpox vaccine, Acambis plc took an order from the feds for 10 million more doses at a price of about $30 million, and disclosed separately that $19 million is due from Novartis AG to settle the dispute over another vaccine.
Still up in the air with the order for 10 million doses of ACAM2000 from the Centers for Disease Control and Prevention (to be supplied from Acambis' existing inventory this year) is the company's bid for a "warm-base" manufacturing contract - that is, one that keeps operations running steadily rather than making batches of vaccine order by order.
...